Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fibroblast growth factor 23 but not copeptin is independently associated with kidney failure and mortality in patients with chronic kidney disease.
Michon-Colin A, Metzger M, Bankir L, Gauci C, Brunel M, Baron S, Prot-Bertoye C, Stengel B, Thervet E, Haymann JP, Boffa JJ, Vrtovsnik F, Flamant M, Houillier P, Prie D, Courbebaisse M; NephroTest Study Group. Michon-Colin A, et al. Clin Kidney J. 2023 Jul 26;16(12):2472-2481. doi: 10.1093/ckj/sfad149. eCollection 2023 Dec. Clin Kidney J. 2023. PMID: 38046034 Free PMC article.
Combining robust urine biomarkers to assess chronic kidney disease progression.
Bienaimé F, Muorah M, Metzger M, Broeuilh M, Houiller P, Flamant M, Haymann JP, Vonderscher J, Mizrahi J, Friedlander G, Stengel B, Terzi F; NephroTest Study Group. Bienaimé F, et al. EBioMedicine. 2023 Jul;93:104635. doi: 10.1016/j.ebiom.2023.104635. Epub 2023 Jun 6. EBioMedicine. 2023. PMID: 37285616 Free PMC article.
Cystatin C-Based Equation to Estimate GFR without the Inclusion of Race and Sex.
Pottel H, Björk J, Rule AD, Ebert N, Eriksen BO, Dubourg L, Vidal-Petiot E, Grubb A, Hansson M, Lamb EJ, Littmann K, Mariat C, Melsom T, Schaeffner E, Sundin PO, Åkesson A, Larsson A, Cavalier E, Bukabau JB, Sumaili EK, Yayo E, Monnet D, Flamant M, Nyman U, Delanaye P. Pottel H, et al. Among authors: vidal petiot e. N Engl J Med. 2023 Jan 26;388(4):333-343. doi: 10.1056/NEJMoa2203769. N Engl J Med. 2023. PMID: 36720134
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
Vidal-Petiot E, Ford I, Greenlaw N, Ferrari R, Fox KM, Tardif JC, Tendera M, Tavazzi L, Bhatt DL, Steg PG; CLARIFY Investigators. Vidal-Petiot E, et al. Lancet. 2016 Oct 29;388(10056):2142-2152. doi: 10.1016/S0140-6736(16)31326-5. Epub 2016 Aug 30. Lancet. 2016. PMID: 27590221 Free article.
Visit-to-visit variability of blood pressure and cardiovascular outcomes in patients with stable coronary heart disease. Insights from the STABILITY trial.
Vidal-Petiot E, Stebbins A, Chiswell K, Ardissino D, Aylward PE, Cannon CP, Ramos Corrales MA, Held C, López-Sendón JL, Stewart RAH, Wallentin L, White HD, Steg PG; STABILITY Investigators. Vidal-Petiot E, et al. Eur Heart J. 2017 Oct 1;38(37):2813-2822. doi: 10.1093/eurheartj/ehx250. Eur Heart J. 2017. PMID: 28575274 Clinical Trial.
88 results